The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin
Dr Shannon Westin from the MD Anderson Cancer Center in Houston, Texas, discusses the role of PARP inhibition in the management of ovarian cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayASCOOvarian20)
